Literature DB >> 16254219

Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study.

Jorge R Kizer1, David O Wiebers, Jack P Whisnant, James M Galloway, Thomas K Welty, Elisa T Lee, Lyle G Best, Helaine E Resnick, Mary J Roman, Richard B Devereux.   

Abstract

BACKGROUND AND
PURPOSE: Mitral annular calcification (MAC) and aortic valve (AV) sclerosis have each been linked to cardiovascular disease. Whether MAC and AV sclerosis are risk factors for stroke independent of other echocardiographic or laboratory predictors has not been established. We evaluated the relationship between MAC, AV sclerosis, and first stroke events in a population-based cohort.
METHODS: Our study cohort consisted of 2723 American Indians participating in the Strong Heart Study who were free of prevalent cardiovascular disease. Participants underwent standardized clinical, echocardiographic, and laboratory evaluation, and incident stroke was ascertained using validated methods.
RESULTS: During a median follow-up of 7 years, 86 strokes occurred. Age- and sex-adjusted incidence rates of stroke were significantly increased for MAC (rate ratio [RR], 3.12; 95% CI, 1.77 to 5.25) but not for AV sclerosis (RR, 1.15; 95% CI, 0.45 to 2.49). MAC was also associated with a reduced time to first stroke events after adjustment for clinical variables and the inflammatory markers C-reactive protein and fibrinogen (hazard ratio [HR], 2.42; 95% CI, 1.39 to 4.21) or the echocardiographic covariates left ventricular hypertrophy and left atrial enlargement (HR, 1.89; 95% CI, 1.04 to 3.41). Individuals with and without AV sclerosis showed no significant difference in stroke-free survival in unadjusted analyses (P=0.698). Crossing of the survival curves precluded multivariable analysis using Cox models.
CONCLUSIONS: In this cohort of American Indians without clinical cardiovascular disease, the presence of MAC, but not AV sclerosis, proved to be a strong risk factor for incident stroke after extensive adjustment for other predictors. Individuals exhibiting MAC may benefit from aggressive risk factor modification, but this will require further investigation.

Entities:  

Mesh:

Year:  2005        PMID: 16254219     DOI: 10.1161/01.STR.0000190005.09442.ad

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

1.  Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Richard P Whitlock; Jack C Sun; Stephen E Fremes; Fraser D Rubens; Kevin H Teoh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.

Authors:  D J H McCabe; R D Rakhit
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01       Impact factor: 10.154

3.  Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis.

Authors:  Sammy Elmariah; Matthew J Budoff; Joseph A C Delaney; Yasmin Hamirani; John Eng; Valentin Fuster; Richard A Kronmal; Jonathan L Halperin; Kevin D O'Brien
Journal:  Am Heart J       Date:  2013-09-26       Impact factor: 4.749

4.  Incidence and risk factors for stroke in American Indians: the Strong Heart Study.

Authors:  Ying Zhang; James M Galloway; Thomas K Welty; David O Wiebers; Jack P Whisnant; Richard B Devereux; Jorge R Kizer; Barbara V Howard; Linda D Cowan; Jeunliang Yeh; W James Howard; Wenyu Wang; Lyle Best; Elisa T Lee
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

Review 5.  The science of stroke: mechanisms in search of treatments.

Authors:  Michael A Moskowitz; Eng H Lo; Costantino Iadecola
Journal:  Neuron       Date:  2010-07-29       Impact factor: 17.173

6.  The novel inflammatory marker GlycA and the prevalence and progression of valvular and thoracic aortic calcification: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Angelica Ezeigwe; Oluwaseun E Fashanu; Di Zhao; Matthew J Budoff; James D Otvos; Isac C Thomas; Samia Mora; Martin Tibuakuu; Erin D Michos
Journal:  Atherosclerosis       Date:  2019-01-24       Impact factor: 5.162

7.  Progression of valvular calcification and risk of incident stroke: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Oluwaseun E Fashanu; Anas Bizanti; Ahmad Al-Abdouh; Di Zhao; Matthew J Budoff; Isac C Thomas; W T Longstreth; Erin D Michos
Journal:  Atherosclerosis       Date:  2020-07-05       Impact factor: 5.162

8.  Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: The Cardiovascular Health Study.

Authors:  Daniele Massera; Shuo Xu; Traci M Bartz; Anna E Bortnick; Joachim H Ix; Michel Chonchol; David S Owens; Eddy Barasch; Julius M Gardin; John S Gottdiener; John R Robbins; David S Siscovick; Jorge R Kizer
Journal:  Arch Osteoporos       Date:  2017-05-30       Impact factor: 2.617

9.  Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography.

Authors:  Maria G Karas; Steven Francescone; Alan Z Segal; Richard B Devereux; Mary J Roman; Jennifer E Liu; Rebecca T Hahn; Jorge R Kizer
Journal:  Am J Cardiol       Date:  2007-03-20       Impact factor: 2.778

Review 10.  Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis.

Authors:  R J M W Rennenberg; A G H Kessels; L J Schurgers; J M A van Engelshoven; P W de Leeuw; A A Kroon
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.